NCT06206265: An ongoing trial by TRYP Therapeutics
This trial is ongoing. It must report results 10 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06206265 |
|---|---|
| Title | A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 17, 2024 |
| Completion date | March 1, 2026 |
| Required reporting date | March 1, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |